2-(4-Methylphenyl)sulfonyl-1,3-dihydroisoquinolin-4-one, 95%, 5g

Fmoc-EDA.HCl, 99.0%, 5g

1H-PYRAZOLO[3,4-D]PYRIMIDINE-4-CARBOXYLIC ACID, 95.0%, 250mg

Ethyl 4-(cyclopropylamino)cyclohexanecarboxylate, 97%, 5g

2-Chlorodibenzo[b,f][1,4]oxazepin-11(10H)-one, 95.0%, 50g

5-Oxo-1- o -tolyl-pyrrolidine-3-carboxylic acid, 95.0%, 1g

1-Bromo-2-ethylbutane (stabilized with Copper chip)>97.0%(GC)5g

1-(1-methyl-1H-1,2,4-triazol-5-yl)-1-propanamine, 95.0%, 250mg

(R)-5-Aminopiperidin-2-one hydrochloride, 95.0%, 10g

N,N-Dimethyl-1-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)methanamine, 95.0%, 250mg

6-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 5g

1-Isopropyl-1H-benzo[d][1,3]oxazine-2,4-dione, 95.0%, 500mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indoline, 95.0%, 250mg